Standout Papers
Citation Impact
Citing Papers
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Can We Define the Ideal Duration of Antibiotic Therapy?
2006
Influence of Antibiotic Therapy on Mortality of Critical Surgical Illness Caused or Complicated by Infection
2005
Duration of Antibiotic Therapy for Ventilator-Associated Pneumonia Caused by Non-Fermentative Gram-Negative Bacilli
2007
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
2012
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients<subtitle>A Randomized Trial</subtitle>
2009 Standout
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
2012
Post–Acute Care Use and Hospital Readmission after Sepsis
2015
Ventilator-Associated Pneumonia
2008
Diagnosis of Ventilator-associated Pneumonia
1997
The safety of targeted antibiotic therapy for ventilator-associated pneumonia: A multicenter observational study
2008
Safety of Combined Heat and Moisture Exchanger Filters in Long-term Mechanical Ventilation
1997
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Cystic Fibrosis Pulmonary Guidelines
2009
Antimicrobial Resistance in the Intensive Care Unit: Mechanisms, Epidemiology, and Management of Specific Resistant Pathogens
2010
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
De-Escalation Therapy: Is It Valuable for the Management of Ventilator-Associated Pneumonia?
2011
A Prospective Comparative Study of Continuous Arteriovenous Hemodiafiltration and Continuous Venovenous Hemodiafiltration in Critically Ill Patients
1993
An Evaluation of the Gram Stain in Protected Bronchoalveolar Lavage Fluid for the Early Diagnosis of Ventilator-Associated Pneumonia
2001
Use of Broad-Spectrum Antimicrobials for the Treatment of Pneumonia in Seriously Ill Patients: Maximizing Clinical Outcomes and Minimizing Selection of Resistant Organisms
2005
De-escalation in lower respiratory tract infections
2006
General Principles of Antimicrobial Therapy
2011
Cystic fibrosis
2016 Standout
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
2007
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Weaning from mechanical ventilation
2007 Standout
Pneumonia Caused by Methicillin‐ResistantStaphylococcus aureus
2008
Gram stain of bronchoalveolar lavage fluid in the early diagnosis of ventilator-associated pneumonia
1999
Invasive approaches to the diagnosis of ventilator-associated pneumonia: A meta-analysis
2005
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit*
2008
Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced
2007
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study
2008
Use of Quantitative Cultures and Reduced Duration of Antibiotic Regimens for Patients with Ventilator-Associated Pneumonia to Decrease Resistance in the Intensive Care Unit
2006
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
2008 Standout
Severe Sepsis and Septic Shock
2013 Standout
Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease
1995
Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia.
1995
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia
2013
Influence of Airway Management on Ventilator-Associated Pneumonia
1998
Antibiotic Utilization and Outcomes for Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative BAL Culture Results
2005
Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard.
1995
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Acute Renal Failure
1996 Standout
Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator‐Associated Pneumonia and Hospital‐Acquired Pneumonia
2010
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Sepsis and septic shock
2018 Standout
Contribution of Blinded, Protected Quantitative Specimens to the Diagnostic and Therapeutic Management of Ventilator-Associated Pneumonia
2005
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial
2000 Standout
Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study
2008
Diagnosis of ventilator-associated pneumonia
2005
Usefulness of Quantitative Cultures of BAL Fluid for Diagnosing Nosocomial Pneumonia in Ventilated Patients
1997
Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy
2006
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment
2012
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
2009
Subthreshold Quantitative Bronchoalveolar Lavage: Clinical and Therapeutic Implications
2008
Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments
1998
Anti-infective research and development—problems, challenges, and solutions
2006
Clinical Practice Guidelines for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia in Adults
2007
Prevention of hospital-associated pneumonia and ventilator-associated pneumonia
2004
Clinical and economic consequences of ventilator-associated pneumonia: A systematic review
2005
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
2009
Airway Mucus Function and Dysfunction
2010 Standout
Drug discovery from medicinal plants
2005 Standout
Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: A meta-analysis
1999
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
2008
De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate
2007
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
Effect From Multiple Episodes of Inadequate Empiric Antibiotic Therapy for Ventilator-Associated Pneumonia on Morbidity and Mortality Among Critically Ill Trauma Patients
2005
Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia
2008
Diagnosis of ventilator-associated pneumonia
2013
INVASIVE DIAGNOSTIC TECHNIQUES FOR PNEUMONIA: PROTECTED SPECIMEN BRUSH, BRONCHOALVEOLAR LAVAGE, AND LUNG BIOPSY METHODS
1998
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
Variation in critical care services across North America and Western Europe*
2008
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
2009
De-escalation therapy in ventilator-associated pneumonia*
2004
Development of a Guideline for the Management of Ventilator-Associated Pneumonia Based on Local Microbiologic Findings and Impact of the Guideline on Antimicrobial Use Practices
2008
Guideline for Prevention of Nosocomial Pneumonia
1994
Durée de l’antibiothérapie lors du traitement des pneumopathies acquises sous ventilation mécanique : comparaison entre sept jours et dix jours. Étude pilote
2008
Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients
2007
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
Multidrug efflux pumps: structure, function and regulation
2018 Standout
Overview of strategies for overcoming the challenge of antimicrobial resistance
2010
Efficacy of Short-Course Antibiotic Regimens for Community-Acquired Pneumonia: A Meta-analysis
2007
Die offiziellen amerikanischen Empfehlungen zur Prävention nosokomialer Pneumonien
1998
Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures*
2013
Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: Diagnosis and treatment
2008
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Diagnosis of Nosocomial Pneumonia in Mechanically Ventilated Patients
1998
Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia
2004
Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated Pneumonia
2004
Ventilator-associated Pneumonia
2002 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Impact of a Guideline on Management of Children Hospitalized With Community-Acquired Pneumonia
2012
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
2015
Extracorporeal therapy requirements for patients with acute renal failure.
1997
Impacto da implantação de um guia terapêutico para o tratamento de pneumonia nosocomial adquirida na unidade de terapia intensiva em hospital universitário
2007
A Randomized Controlled Trial of an Antibiotic Discontinuation Policy for Clinically Suspected Ventilator-Associated Pneumonia
2004
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
The Effect of Blind-Protected Specimen Brush Sampling on Antibiotic Use in Patients with Suspected Ventilator-Associated Pneumonia
2001
An Evaluation of the Gram Stain in Protected Bronchoalveolar Lavage Fluid for the Early Diagnosis of Ventilator-Associated Pneumonia
2001
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Antimicrobial treatment of hospital-acquired pneumonia
2003
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Legionella and Legionnaires' Disease: 25 Years of Investigation
2002 Standout
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia.
1996
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Burn Wound Infections
2006 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients
1998 Standout
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
Duration of Antibiotic Treatment in Community-Acquired Pneumonia
2016
Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey
2012
Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia
2013
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
The Effect of Blind-Protected Specimen Brush Sampling on Antibiotic Use in Patients with Suspected Ventilator-Associated Pneumonia
2001
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa
2007
Works of S. Aubas being referenced
Bronchoalveolar lavage for diagnosing bacterial pneumonia in mechanically ventilated patients.
1994
Comparison of hydrophobic heat and moisture exchangers with heated humidifier during prolonged mechanical ventilation
1992
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Pump assisted continuous venovenous hemofiltration for treating acute uremia.
1988